FDA Designation for Bristol-Myers Candidate
moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, click here to view […]
BMY
UPDATE 1-FDA approves Bristol-Myers drug for rare body fat disorder
[Reuters – UK Focus] – (Corrects throughout to change source to U.S. Food and Drug Administration from Bristol-Myers Squibb. Feb 25 (Reuters) – The U.S. Food and Drug Administration said it approved Bristol-Myers Squibb Co’s drug to treat rare and potent moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol […]
FDA approves Bristol-Myers drug for rare body fat disorder
[Reuters – UK Focus] – Bristol-Myers Squibb Co said the U.S. Food and Drug Administration approved its drug to treat rare and potentially fatal disorders involving loss of body fat. The drug has been approved as a replacement therapy to treat complicatio moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who […]
FDA clears Bristol drug for rare fat disorder
moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, click here to view […]
FDA approves Bristol-Myers’ drug for rare fat disorder
moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, click here to view […]
8:32 am Bristol-Myers Receives U.S. FDA Breakthrough Therapy Designation for All-Oral Daclatasvir Dual Investigational Regimen for Chronic Hepatitis C
moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, click here to view […]
Bristol-Myers Squibb Receives U.S. FDA Breakthrough Therapy Designation for All-Oral Daclatasvir Dual Investigational Regimen for Chronic Hepatitis C
[Business Wire] – Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has granted its investigational DCV Dual Regimen Breakthrough Therapy Designation for use as a combination therapy in the treatment of genotype 1b c moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, […]
11:08 am Bristol-Myers and Pfizer: In a subanalysis, Eliquis (apixaban) reduced the risk of stroke and demonstrated fewer major bleeding events versus warfarin
moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, click here to view […]
Dividend Derby: Pfizer Vs. Merck
moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, click here to view […]
Can Bristol-Myers Squibb Beat the S&P in 2014?
moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, click here to view […]
